uic-94003 has been researched along with vicriviroc in 1 studies
| Studies (uic-94003) | Trials (uic-94003) | Recent Studies (post-2010) (uic-94003) | Studies (vicriviroc) | Trials (vicriviroc) | Recent Studies (post-2010) (vicriviroc) |
|---|---|---|---|---|---|
| 18 | 0 | 4 | 101 | 20 | 36 |
| Protein | Taxonomy | uic-94003 (IC50) | vicriviroc (IC50) |
|---|---|---|---|
| C-C chemokine receptor type 5 | Homo sapiens (human) | 0.0016 | |
| C-C chemokine receptor type 5 | Mus musculus (house mouse) | 0.0009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E | 1 |
1 review(s) available for uic-94003 and vicriviroc
| Article | Year |
|---|---|
New approaches toward anti-HIV chemotherapy.
Topics: Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; CD4 Antigens; HIV Integrase Inhibitors; HIV Protease Inhibitors; HIV-1; Humans; Nucleosides; Nucleotides; Receptors, CXCR4; Reverse Transcriptase Inhibitors; Ribonuclease H; Transcription, Genetic; Transcriptional Activation | 2005 |